• Executed binding Term Sheet for Joint Development Agreement with US-based Black Diamond Structures
• Wyon AG commenced trials of Ultranodē for potential commercial use
• Achieved key technical milestones for Ultranodē X anode material

AnteoTech Ltd (ASX: ADO) reported its Appendix 4C Quarterly Cashflow Report and Activities Update for the period ended 30 June 2025. Key highlights include: Advanced Battery Technologies - Executed a binding Term Sheet for a Joint Development Agreement with US-based Black Diamond Structures to co-develop a combined advanced battery product. Wyon AG commenced trials of Ultranodē for potential commercial use. Achieved key technical milestones for Ultranodē X, including 890 cycles at 80% capacity retention and 1,070 cycles at 70% capacity retention. Life Sciences - Received a $213,000 AnteoBindā¢ sales order from the Serum Institute of India. Successfully completed a prototype assay development program for KOMA in South Korea. Corporate - Completed a Strategic Review, realigning resources and capabilities with a focus on execution and revenue generation. Undertook an organisational restructure to deliver estimated annual cost savings of ~$1.6 million. Appointed Merrill Gray as Interim Managing Director and CEO.

The company reported a closing cash balance of $2.7 million at 30 June 2025. Post period, the company has lodged its annual tax return for FY2025 which contains an R&D tax rebate claim for approximately $2.6 million, giving a pro-forma cash balance as at 30 June 2025 of $5.3 million.

The company is prioritizing activities and resources to deliver against its strategic review outcomes, with a focus on accelerating revenue generation through market expansion, advancing strategic partnerships, and reducing corporate and administrative costs. The company is well positioned to capitalize on the foundations it has laid, with growing commercial interest, an expanding global presence, and a clear path to market.